REVAIA and PARTECH invest €35 million in the next generation of healthcare software

For the past two decades, the digital transformation of businesses has been organised around two major categories of software infrastructure. ERP systems structured internal operations, while CRM platforms centralised customer relationships. In healthcare, a new category of platform is now emerging: the “Care Operating System”, designed to orchestrate the entire care pathway, from medical data and administrative workflows to the artificial intelligence agents of the future.

This evolution lies at the heart of the strategy pursued by Semble, a European company specialising in care management and coordination software. The company has announced a €35 million funding round led by Revaia, with participation from Partech and renewed backing from Mercia Ventures and Octopus Ventures.

The deal comes as European healthcare systems undergo a profound transformation. Ageing populations, shortages of healthcare professionals, rapidly expanding volumes of medical data and the rise of artificial intelligence are forcing healthcare organisations to rethink how they operate.

Fragmentation has become the main problem

Over the past two decades, the digitalisation of healthcare has been built through successive layers. One system for appointments. Another for medical records. A third for billing. Others for telemedicine, prescriptions, care coordination or patient communications.

This accumulation of solutions has modernised many processes, but it has also created a new problem: fragmentation.

“For years, the industry has attempted to solve complex systemic problems through isolated and disconnected solutions. But fragmented technology often adds operational complexity for healthcare professionals and creates a disjointed experience for patients,” says Christoph Lippuner, co-founder and CEO of Semble.

The challenge is therefore no longer simply to digitalise healthcare, but to connect all the professionals, data and tools involved throughout the patient journey.

The operating system for healthcare

This is precisely the layer on which Semble is seeking to position itself. The company is developing a unified platform for independent healthcare professionals, medical centres and care organisations. Its software coordinates clinical data, administrative tasks, information flows and interactions between the various professionals involved.

More than ten million patients have been managed through Semble’s platform, which serves over 1,700 healthcare organisations and nearly 16,000 daily users. The platform also integrates with more than 1,200 third-party solutions spanning the healthcare ecosystem, from appointment booking and diagnostics to billing and patient relationship management.

This open-platform approach is a central component of its strategy.

“The healthcare organisations that succeed over the next ten years will be those built on open and interoperable systems capable of connecting data, professionals and care pathways within a unified patient experience,” says Christoph Lippuner.

For Morgan Kessous, Partner at Revaia, the ambition extends far beyond specialised business software: “Semble is building the operating system for modern healthcare: a platform combining genuine clinical depth, the ability to deploy at scale and the trust of healthcare professionals.”

A European battle is underway

Semble is not alone in this race. In the United States, Epic Systems and Athenahealth already play a central role in the digital infrastructure of hospitals and medical practices. Oracle has been pursuing a similar ambition since acquiring Cerner for nearly $28 billion.

Europe’s market remains more fragmented. Doctolib is gradually expanding beyond appointment booking to become a broader patient journey management platform. In Germany, CompuGroup Medical retains a dominant position among many healthcare professionals. In the United Kingdom, Accurx has established itself as a major player in coordination between practitioners and patients.

Competition, however, is no longer coming solely from established software providers. A new generation of artificial intelligence companies, including Nabla, Corti and Tortus, is seeking to become the primary interface used by healthcare professionals. Their ambition is not necessarily to replace existing software, but to position themselves above it by automating a growing share of administrative and clinical work.

Controlling the patient journey is therefore becoming a strategic issue comparable to the role once played by ERP systems in industry or CRM platforms in sales organisations.

France, a new market for expansion

France occupies a distinctive place in Semble’s strategy. The market is being rapidly reshaped by the growth of multidisciplinary healthcare centres, medical clinics and private care groups. More than 200,000 doctors are seeing their working models evolve towards more collaborative structures that require more advanced coordination tools.

Semble has opened offices in Paris and Toulouse and says it has tripled its French workforce since December 2024. The company also obtained LAP HAS v2 and Ségur V1 certifications in less than a year, two essential requirements for operating at scale in the French market.

“Semble has built the infrastructure required to orchestrate patient journeys within increasingly complex and highly regulated healthcare systems,” says Rémi Said, General Partner at Partech.

AI could accelerate market consolidation

The arrival of artificial intelligence is further increasing the strategic value of these platforms. Companies that already control data, workflows and interactions between healthcare professionals have a decisive advantage when deploying assistants capable of drafting clinical notes, coordinating care, preparing consultations or automating administrative tasks.

Semble plans to use the new funding to accelerate the development of its care orchestration and artificial intelligence capabilities.